Logo

Aura Biosciences, Inc.

AURA

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, i… read more

Healthcare

Biotechnology

1 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$6.15

Price

-0.57%

-$0.03

Market Cap

$381.727m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$1.238m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$101.378m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.96

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$174.629m

$204.397m

Assets

$29.768m

Liabilities

$18.112m

Debt
Debt to Assets

8.9%

-0.2x

Debt to EBITDA
Free Cash Flow

-$84.220m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases